|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 5 733-747, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
HH Guldner, C Szostecki, P Schroder, U Matschl, K Jensen, C Luders, H Will and T Sternsdorf
Heinrich-Pette-Institut fur experimentelle Virologie und Immunologie an der Universitat Hamburg, Martinistr. 52, D-20251 Hamburg, Germany.
Sp100 and PML are interferon-inducible proteins associated with a new class of nuclear domains (known as nuclear dots or PML bodies) which play a role in tumorigenesis, virus infections, and autoimmunity. While PML is extensively alternatively spliced, only two splice variants are known for Sp100. Here we describe the identification and characterization of several Sp100 splice variant proteins and support their existence by elucidation of the 3'-end of the Sp100 gene. Some of the splice variants contain a domain of significant sequence similarity with two previously described highly related interferon-inducible nuclear phosphoproteins as well as to suppressin and DEAF-1, which altogether define a novel protein motif, termed HNPP-box. One class of splice variants contains an almost complete and highly conserved copy of the DNA-binding high mobility group 1 protein sequence and thus represent novel HMG-box proteins. When expressed transiently, both major classes of Sp100 splice variant proteins localize in part to nuclear dots/PML bodies and in addition to different nuclear domains. Furthermore, PML was occasionally redistributed. These data indicate that alternatively spliced Sp100 proteins are expressed, differ in part in localization from Sp100, and might bind to chromatin via the HMG domain.
This article has been cited by other articles:
![]() |
Y.-C. M. Chen, C. Kappel, J. Beaudouin, R. Eils, and D. L. Spector Live Cell Dynamics of Promyelocytic Leukemia Nuclear Bodies upon Entry into and Exit from Mitosis Mol. Biol. Cell, July 1, 2008; 19(7): 3147 - 3162. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Everett, C. Parada, P. Gripon, H. Sirma, and A. Orr Replication of ICP0-Null Mutant Herpes Simplex Virus Type 1 Is Restricted by both PML and Sp100 J. Virol., March 15, 2008; 82(6): 2661 - 2672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. MANUEL LUCENA, M. MONTES CANO, J. LUIS CARO, N. RESPALDIZA, A. ALVAREZ, J. SANCHEZ-ROMAN, A. NUNEZ-ROLDAN, and I. WICHMANN Comparison of Two ELISA Assays for Anti-Sp100 Determination Ann. N.Y. Acad. Sci., August 1, 2007; 1109(1): 203 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Everett, S. Rechter, P. Papior, N. Tavalai, T. Stamminger, and A. Orr PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0. J. Virol., August 1, 2006; 80(16): 7995 - 8005. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wasylyk, S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity Mol. Cell. Biol., April 15, 2002; 22(8): 2687 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Manne, B. D. Gary, D. K. Oelschlager, H. L. Weiss, A. R. Frost, and W. E. Grizzle Altered Subcellular Localization of Suppressin, a Novel Inhibitor of Cell-Cycle Entry, Is an Independent Prognostic Factor in Colorectal Adenocarcinomas Clin. Cancer Res., November 1, 2001; 7(11): 3495 - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Seeler, A. Marchio, R. Losson, J. M. P. Desterro, R. T. Hay, P. Chambon, and A. Dejean Common Properties of Nuclear Body Protein SP100 and TIF1{alpha} Chromatin Factor: Role of SUMO Modification Mol. Cell. Biol., May 15, 2001; 21(10): 3314 - 3324. [Abstract] [Full Text] |
||||
![]() |
D Negorev, A. Ishov, and G. Maul Evidence for separate ND10-binding and homo-oligomerization domains of Sp100 J. Cell Sci., January 1, 2001; 114(1): 59 - 68. [Abstract] [PDF] |
||||
![]() |
S. Kaul, J. A. Blackford Jr., J. Chen, V. V. Ogryzko, and S. S. Simons Jr. Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins Mol. Endocrinol., July 1, 2000; 14(7): 1010 - 1027. [Abstract] [Full Text] |
||||
![]() |
J. Pitkanen, V. Doucas, T. Sternsdorf, T. Nakajima, S. Aratani, K. Jensen, H. Will, P. Vahamurto, J. Ollila, M. Vihinen, et al. The Autoimmune Regulator Protein Has Transcriptional Transactivating Properties and Interacts with the Common Coactivator CREB-binding Protein J. Biol. Chem., May 26, 2000; 275(22): 16802 - 16809. [Abstract] [Full Text] [PDF] |
||||